found semaglutide Research published today might leave a bad taste in your mouth and a crinkle in your nose if you're taking a GLP-1 medication like (the active ingredient in Ozempic and Wegovy) Wednesday briefing: The study that

Of these, beyond type 2 diabetes, obesity, and sleep apnea, cardiovascular disease is the only illness for which there is enough evidence to receive FDA approval

And once you try it for 30 days and if you see slight benefit of [00:46:00] it then it's the best thing that can happen to you for the rest of your life

This slowing of gastric emptying contributes to Ozempic's therapeutic effect, alongside its primary action on appetite and satiety centres in the brain

The FDA also approved the oral Wegovy pill, providing a non-injection option for patients as of December 2025

The cardiovascular risk associated with hyperglycemia in diabetes is explained by the atherogenic process substantiated by the increased ROS formation

Patients with certain variants may experience stronger delayed gastric emptying at standard doses, meaning they're more prone to burping and bloating but also tend to achieve faster weight loss